Lion Partners with SAP Founder to Acquire Axaron Bioscience and Build New Drug-Development Firm | GenomeWeb

NEW YORK, July 6 (GenomeWeb News) - Lion Bioscience said yesterday that it has acquired the operational business of Axaron Bioscience to create a drug-development firm with a focus on central nervous system disorders.    

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.